Overview

Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis

Status:
Unknown status

Trial end date:
2011-09-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate and compare the efficacy of the sequential association RV4104A ointment followed by ciclopiroxolamine 1% cream and ciclopirox 8% film-forming solution versus amorolfine 5% nail lacquer alone in the treatment of patients with dermatophytic onychomycosis (toenail) without matrix involvement.

Phase:

Phase 4

Details

Lead Sponsor:

Pierre Fabre Dermo Cosmetique

Collaborator:

Quanta Medical

Treatments:

Amorolfine
Antifungal Agents
Ciclopirox
Clotrimazole
Keratolytic Agents
Miconazole